Location: Home
  • search
  • go
  • Relate News
  • 5/23/2025Recent Executive Moves
  • 5/22/2025NMPA Approves Bayer's Eylea 8 mg for nAMD
  • 5/22/2025China Approves Hengrui's Camrelizumab-Famitinib Combo
  • 5/21/2025China Approves InnoCare's Tafasitamab for R/R DLBCL
  • 5/21/2025China Surges Ahead in Oncology Licensing, GlobalData Reports
  • 5/21/2025China's Drugstores Decline Amid Boom in Online Healthcare
  • 5/20/2025Pfizer Enters into $6B Exclusive Licensing Agreement with 3SBio
  • 5/20/2025Evive Bio Partners with LENIS Farma to Expand Ryzneuta® Distribution ...
  • 5/20/2025JHM Secures Strategic Investment to Advance Synthetic Biology Innovati...
  • 5/20/2025WuXi Bio Transfers Leverkusen Facility to Terumo in €150 Million Deal
  • 5/20/2025SparX and Mitsubishi Tanabe Forge Strategic ADC Research Collaboration
  • 5/20/2025CSPC Pharma's JMT106 Approved for Clinical Trials in China and the U.S...
  • 5/16/2025US Push to Decouple from China May Spike Drug Costs, Experts Warn
  • 5/16/2025WuXi Biologics Offloads German Plant to Terumo, Refocuses on Singapore...
  • 5/16/2025SMEI: China's Pharmaceutical Industry Seeks Stability and Innovation A...
  • 5/15/2025NMPA Approves Novartis' Scemblix for First-Line Treatment of Chronic M...
  • 5/14/2025NMPA Approves IND for YL242: An ADC Targeting Soluble VEGF M
  • 5/14/2025Beam Secures RMAT Designation for BEAM-302, a Base Editing Therapy for...
  • 5/14/2025RemeGen's Disitamab Vedotin Plus Toripalimab Shows Promise for HER2-Po...
  • 5/14/2025CTTQ's Anlotinib-Penpulimab Combo Extends Survival in First-Line Advan...
  • 5/14/2025R&D Spending Rises at 276 Chinese Drugmakers Despite Revenue Pressures
  • 5/13/2025China Expands Geriatric Services at Major Hospitals as Elderly Populat...
  • 5/12/2025Lepu's Miracogen Launches Phase 3 Trial of Novel EGFR-Targeting ADC Co...
  • 5/12/2025METiS Eyes US$200M Hong Kong IPO as AI Drug Sector Heats Up
  • 5/12/2025Trump's Drug Pricing and the US-China Trade Deal: "Our Interests are D...
  • 5/10/2025~30% of Chinese Listed Pharma Cos Achieve Double Growth in Revenue and...
  • 5/10/2025China's BMI Fund Reports Big Surplus in Q1/2025
  • 5/10/2025Roche Invests Nearly $300M to Build Vabysmo Manufacturing Hub in Shang...
  • 5/10/2025Qilu Secures Greater China Rights to Minghui's B7-H3 ADC in $38M Deal
  • 5/10/2025China's Public Hospitals Grapple with Mounting Debt Amid Reforms and E...
  • Page:3/359 Total number of articles:10756: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group